Lyra Therapeutics
Allison Nance is a seasoned professional in regulatory affairs with over 30 years of experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Vice President of Regulatory Affairs at Lyra Therapeutics since May 2023, Nance has held previous leadership roles including Senior Vice President at Jounce Therapeutics and Executive Director at Celgene Corporation. Nance has a strong background in regulatory strategy for innovative therapies, particularly in the areas of cancer immunotherapy and chronic inflammatory diseases. Educational achievements include a Master of Science in Biotechnology from Johns Hopkins University and dual Bachelor of Science degrees in Ecology and Evolutionary Biology and Biology from the University of Arizona.
Lyra Therapeutics
Creating precisely tuned medicines so patients can breathe freely, Lyra Therapeutics is pioneering a new therapeutic approach to treat debilitating ear, nose and throat diseases that impact the lives of millions of people.